Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 3
Submit an article Journal homepage
89
Views
0
CrossRef citations to date
0
Altmetric
Continuing Medical Education Credit

Advanced heart failure with reduced ejection fraction

Albert Hicks IIIDivision of Cardiology, Baylor Scott and White Medical Center – Temple, Temple, Texas;
, MD, MPH,
Jorge F. VelazcoDivision of Pulmonary and Critical Care Medicine, Baylor Scott and White Medical Center – Temple, Temple, Texas;
, MD,
Salman GoharDivision of Cardiology, Baylor Scott and White Medical Center – Temple, Temple, Texas;
, MD,
Ahmed SeliemBaylor Scott & White Advanced Heart Failure Clinic, Baylor University Medical Center, Dallas, Texas
, MD,
Shelley A. HallBaylor Scott & White Advanced Heart Failure Clinic, Baylor University Medical Center, Dallas, TexasORCID Iconhttp://orcid.org/0000-0002-5989-2934
, MDORCID Icon &
Jeffrey B. MichelDivision of Cardiology, Baylor Scott and White Medical Center – Temple, Temple, Texas; Correspondence[email protected]
, MD
Pages 350-356 | Received 18 Nov 2019, Accepted 20 Feb 2020, Published online: 02 Jun 2020

  • Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail. 2017;19(5):595–602. doi:10.1002/ejhf.779.
  • Xanthakis V, Enserro DM, Larson MG, et al. Prevalence, neurohormonal correlates, and prognosis of heart failure stages in the community. JACC Heart Fail. 2016;4(10):808–815. doi:10.1016/j.jchf.2016.05.001.
  • Lund LH, Edwards LB, Dipchand AI, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-third adult heart transplantation report—2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35(10):1158–1169. doi:10.1016/j.healun.2016.08.017.
  • Kirklin JK, Cantor R, Mohacsi P, et al. First annual IMACS report: a global International Society for Heart and Lung Transplantation registry for mechanical circulatory support. J Heart Lung Transplant. 2016;35(4):407–412. doi:10.1016/j.healun.2016.01.002.
  • Thorvaldsen T, Lund LH. Focusing on referral rather than selection for advanced heart failure therapies. Card Fail Rev. 2019;5(1):24–26. doi:10.15420/cfr.2018.35.1.
  • Yancy CW, Januzzi JL Jr, Allen LA, et al. 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018;71(2):201–230. doi:10.1016/j.jacc.2017.11.025.
  • CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316(23):1429–1435. doi:10.1056/NEJM198706043162301.
  • Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN, SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325(5):293–302. doi:10.1056/NEJM199108013250501.
  • Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325(5):303–310. doi:10.1056/NEJM199108013250502.
  • McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993–1004. doi:10.1056/NEJMoa1409077.
  • Packer M, Califf RM, Konstam MA, et al. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE). Circulation. 2002;106(8):920–926. doi:10.1161/01.CIR.0000029801.86489.50.
  • Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA. 2005;293(15):1900–1905. doi:10.1001/jama.293.15.1900.
  • Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016;68(13):1476–1488. doi:10.1016/j.jacc.2016.05.011.
  • Baran DA. Extracorporeal membrane oxygenation (ECMO) and the critical cardiac patient. Curr Transplant Rep. 2017;4(3):218–225. doi:10.1007/s40472-017-0158-5.
  • Meuwese CL, Ramjankhan FZ, Braithwaite SA, et al. Extracorporeal life support in cardiogenic shock: indications and management in current practice. Neth Heart J. 2018;26(2):58–66. doi:10.1007/s12471-018-1073-9.
  • Guglin M, Zucker MJ, Bazan VM, et al. Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol. 2019;73(6):698–716. doi:10.1016/j.jacc.2018.11.038.
  • Pineton de Chambrun M, Bréchot N, Combes A. Venoarterial extracorporeal membrane oxygenation in cardiogenic shock: indications, mode of operation, and current evidence. Curr Opin Crit Care. 2019;25(4):397–402. doi:10.1097/MCC.0000000000000627.
  • King CS, Roy A, Ryan L, Singh R. Cardiac support: emphasis on venoarterial ECMO. Crit Care Clin. 2017;33(4):777–794. doi:10.1016/j.ccc.2017.06.002.
  • Lescouflair T, Figura R, Tran A, Kilic A. Adult veno-arterial extracorporeal life support. J Thorac Dis. 2018;10(Suppl 15):S1811–S1818. doi:10.21037/jtd.2018.01.25.
  • Poptsov V, Spirina E, Dogonasheva A, Zolotova E. Five years’ experience with a peripheral veno-arterial ECMO for mechanical bridge to heart transplantation. J Thorac Dis. 2019;11(S6):S889–S901. doi:10.21037/jtd.2019.02.55.
  • Pappalardo F, Schulte C, Pieri M, et al. Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail. 2017;19(3):404–412. doi:10.1002/ejhf.668.
  • Sun T, Guy A, Sidhu A, et al. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for emergency cardiac support. J Crit Care. 2018;44:31–38. doi:10.1016/j.jcrc.2017.10.011.
  • Nersesian G, Hennig F, Müller M, et al. Temporary mechanical circulatory support for refractory heart failure: the German Heart Center Berlin experience. Ann Cardiothorac Surg. 2019;8(1):76–83. doi:10.21037/acs.2018.12.01.
  • Cevasco M, Takayama H, Ando M, Garan AR, Naka Y, Takeda K. Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation. J Thorac Dis. 2019;11(4):1676–1683. doi:10.21037/jtd.2019.03.29.
  • Barge-Caballero G, Castel-Lavilla MA, Almenar-Bonet L, et al. Venoarterial extracorporeal membrane oxygenation with or without simultaneous intra-aortic balloon pump support as a direct bridge to heart transplantation: results from a nationwide Spanish registry. Interact Cardiovasc Thorac Surg. 2019;29(5):670–677. doi:10.1093/icvts/ivz155.
  • Martits-Chalangari K, Hernandez O, Jamil AK, et al. Salvage of severe primary graft dysfunction following heart transplantation using extracorporeal life support. Proc (Bayl Univ Med Cent). 2018;31(4):482–486. doi:10.1080/08998280.2018.1498724.
  • Guha A, Hannawi B, Cruz-Solbes AS, et al. Implication of ventricular assist devices in extracorporeal membranous oxygenation patients listed for heart transplantation. J Clin Med. 2019;8(5):572–584. doi:10.3390/jcm8050572.
  • Urban M, Siddique A, Merritt-Genore H, Um J. What are the results of venoarterial extracorporeal membrane oxygenation bridging to heart transplantation? Interact Cardiovasc Thorac Surg. 2019;29(4):632–634. doi:10.1093/icvts/ivz096.
  • Tramm R, Ilic D, Davies AR, Pellegrino VA, Romero L, Hodgson C. Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database Syst Rev. 2015;1:CD010381. doi:10.1002/14651858.CD010381.pub2.
  • Pozzi M, Banfi C, Grinberg D, et al. Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients. J Thorac Dis. 2016;8(7):E495–E502. doi:10.21037/jtd.2016.06.26.
  • Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Cardinal considerations for initiation and management. Circ Heart Fail. 2018;11(9):1–17. doi:10.1161/CIRCHEARTFAILURE.118.004905.
  • Schiller P, Hellgren L, Vikholm P. Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score. Eur Heart J Acute Cardiovasc Care. 2019;8(4):329–337. doi:10.1177/2048872618799745.
  • Mehmood M. Venoarterial extracorporeal membrane oxygenation in the new heart allocation scheme: time for concern or time to get our act together? Circ Heart Fail. 2018;11(9):1–2. doi:10.1161/CIRCHEARTFAILURE.118.005322.
  • Le Gall A, Follin A, Cholley B, Mantz J, Aissaoui N, Pirracchio R. Veno-arterial-ECMO in the intensive care unit: from technical aspects to clinical practice. Anaesth Crit Care Pain Med. 2018;37(3):259–268. doi:10.1016/j.accpm.2017.08.007.
  • Liotta D, Taliani T, Giffoniello AH, et al. Artificial heart in the chest: preliminary report. Trans Am Soc Artif Intern Organs. 1961;7:318–322.
  • Liotta D, Hall CW, Henly WS, Cooley DA, Crawford ES, Debakey ME. Prolonged assisted circulation during and after cardiac or aortic surgery. Prolonged partial left ventricular bypass by means of intracorporeal circulation. Am J Cardiol. 1963;12(3):399–405. doi:10.1016/0002-9149(63)90235-2.
  • Hall CW, Liotta D, Henly WS, Crawford ES, DeBakey ME. Development of artificial intrathoracic circulatory pumps. Am J Surg. 1964;108(5):685–692. doi:10.1016/0002-9610(64)90115-1.
  • US Department of Health and Human Services. Artificial Heart and Assist Devices: Directions, Needs, Costs, Societal and Ethical Issues. Bethesda, MD: National Institutes of Health; 1985: 25–27.
  • Institute of Medicine. The Artificial Heart: Prototypes, Policies, and Patients. Hogness JR, VanAntwerp M, eds. Washington, DC: National Academies Press; 1991.
  • Frazier OH, Duncan JM, Radovancevic B, et al. Successful bridge to heart transplantation with a new left ventricular assist device. J Heart Lung Transplant. 1992;11(3 Pt 1):530–537.
  • Aaronson KD, Slaughter MS, Miller LW, et al; HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125(25):3191–3200. doi:10.1161/CIRCULATIONAHA.111.058412.
  • Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376(5):451–460. doi:10.1056/NEJMoa1602954.
  • Milano CA, Rogers JG, Tatooles AJ, et al. HVAD: the ENDURANCE supplemental trial. JACC Heart Fail. 2018;6(9):792–802. doi:10.1016/j.jchf.2018.05.012.
  • Naftel DC, Kirklin JK, Myers SL. INTERMACS Statistical Report: March 1, 2006 – August 31, 2007. www.intermacs.org.
  • Mehra MR, Naka Y, Uriel N, et al; MOMENTUM 3 investigators. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376(5):440–450. doi:10.1056/NEJMoa1610426.
  • Mehra MR, Uriel N, Naka Y, et al; MOMENTUM 3 investigators. A fully magnetically levitated left ventricular assist device—final report. N Engl J Med. 2019;380(17):1618–1627. doi:10.1056/NEJMoa1900486.
  • Mehta SM, Pae WE Jr, Rosenberg G, et al. The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg. 2001;71(3 Suppl):S156–S161. doi:10.1016/S0003-4975(00)02641-2.
  • Dowling RD, Gray LA, Jr, Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg. 2004;127(1):131–141. doi:10.1016/j.jtcvs.2003.07.023.
  • Pya Y, Maly J, Bekbossynova M, et al. First human use of a wireless coplanar energy transfer coupled with a continuous-flow left ventricular assist device. J Heart Lung Transplant. 2019;38(4):339–343. doi:10.1016/j.healun.2019.01.1316.
  • Mehra MR, Salerno C, Cleveland JC, et al. Healthcare resource use and cost implications in the MOMENTUM 3 long-term outcome study. Circulation. 2018;138(18):1923–1934. doi:10.1161/CIRCULATIONAHA.118.035722.
  • Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov/. Accessed February 10, 2020.
  • Emdin CA, Hsiao AJ, Kiran A, et al. Referral for specialist follow-up and its association with post-discharge mortality among patients with systolic heart failure (from the National Heart Failure Audit for England and Wales). Am J Cardiol. 2017;119(3):440–444. doi:10.1016/j.amjcard.2016.10.021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.